Tryal announced the launch of the new Tryal Accelerator, a next-generation AI-powered platform designed to dramatically improve the speed, quality, and consistency of clinical trial startup documentation. Built for sponsors, CROs, and biotechs, Tryal Accelerator turns the historically fragmented, manual process of assembling study materials into a streamlined, compliant, and intelligence-driven workflow.

Health Technology Insights: EDX Medical to Launch Advanced Bowel Cancer Test in UK

A Solution to Fragmented, Manual Clinical Operations

“We must find ways to decrease the time it takes to startup clinical studies, or many promising therapies will not make it to patients in need. Tryal Accelerator focuses on making study startup faster, helping sponsors and CRO’s accelerate clinical trials….with confidence.”

Across the life sciences industry, critical operational decisions remain scattered across spreadsheets, documents, meetings, emails, and slide decks, which makes consistency difficult, slows timelines, and increases compliance risk. Study startup is particularly affected: aligning cross-functional teams, drafting core documents, and updating materials after protocol changes can take weeks of effort and are prone to error.

Health Technology Insights: Celltrion Wins CHMP Support for SteQeyma Autoinjector

Tryal Accelerator directly addresses these long-standing problems by giving clinical teams a unified, intelligent system to generate, update, and manage documentation based on curated, study-specific source materials such as protocols, meeting notes, spreadsheets, prior documents, video and emails.

“With new technologies making drug discovery faster and more precise, we must find ways to decrease the time it takes to startup clinical studies, or many promising therapies will not make it to patients in need. Tryal Accelerator focuses on making study startup faster, helping sponsors and CRO’s accelerate clinical trials… with confidence.” – Shae Wilkins, CEO of Tryal, Inc.

AI-Powered Document Generation, Purpose-Built for Regulated Environments

Tryal Accelerator’s differentiated approach solves key industry gaps by combining structured inputs, domain-specific logic, and a study-specific knowledge base developed exclusively from sponsor-provided materials. This approach ensures accuracy, reduces hallucinations, enables traceability, and grounds every output in approved content.

Key capabilities include:

  • Comprehensive Document Generation from User-Controlled Inputs – The platform creates high-quality drafts using information from protocols, transcripts, emails, and other approved documents, going far beyond tools that rely solely on the protocol.
  • Configurable Smart Templates and Integrated Collaboration – Teams can draft, edit, and refine documents within an integrated workspace, with multi-user editing, and AI assistance available throughout.
  • Impact Assessment Across Documentation – When a visit, procedure, or operational detail changes, Tryal identifies all affected documents and surfaces required updates, reducing rework and protecting downstream alignment.
  • Compliance and Traceability by Design – Each input and action is automatically tracked, supporting 21 CFR Part 11 alignment, GxP expectations, and audit-ready transparency. Accelerator maps every text section back to the exact part of the source file it came from

Accelerating Study Startup for Sponsors, CROs, and Biotechs

Tryal Accelerator is purpose-built to solve the pressures sponsors and CROs face to shorten timelines, manage increased protocol complexity, and maintain accuracy across an expanding volume of documents. Sponsors must implement AI responsibly within tightly controlled environments, while CROs must demonstrate innovation and efficiency to remain competitive. Tryal Accelerator bridges these needs by offering automation that is controlled, compliant, and grounded in how clinical teams actually work.

“Tryal’s knowledge base paired with AI turns hours of work into minutes, and is a game-changer when creating study related documents.” – Healthcare Technology Executive

“I no longer start from scratch. The combination of intelligent templates and a living knowledge base ensures every document is fast, consistent, and accurate. We’re now focused on the finer details that matter which greatly increases our efficiency and effectiveness.” – Clinical Trial Recruitment Principal

A Platform Designed for the Future of Clinical Development

According to the company’s long-term vision, Tryal Accelerator is only the beginning. While the platform initially focuses on clinical trial startup, Tryal aims to expand across the entire clinical development lifecycle, unlocking the full value of structured information and enabling smarter execution from startup through conduct and beyond.

Health Technology Insights: Cosan Secures Growth Funding to Expand AI Virtual Care

To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com